Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Current treatments for alopecia show no significant long-term benefits.

Laser device increases hair density, safe for treating hair loss in men and women.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

PRP injections improve hair thickness for baldness.

UV radiation can help sterilize wounds and promote healing but requires careful use to avoid damaging cells.

The guideline offers current advice for diagnosing and treating Long- and Post-COVID symptoms.

The document concludes that dandruff and seborrheic dermatitis are linked to inflammation and skin changes, and treating them with specific shampoos can reduce these issues.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

Different types of facial fat affect aging and treatment outcomes; more research is needed to enhance anti-aging procedures.

Certain bacteria and fungi are linked to healthy scalps and dandruff, suggesting that the scalp's microbial balance affects its health.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Caucasian women's hair appears thickest in their 20s, with perceived thinning after mid-30s due to both decreasing density and diameter.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Some alternative treatments for hair loss might work, but more research is needed.

The research found genetic differences in identical twins that could explain why one twin has a disease while the other does not.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Azelaic acid is effective for treating rosacea, acne, and melasma.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Consider benefits and risks of new alopecia treatments for safety.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.